The biology of the pilosebaceous unit has attracted the attention of numerous investigators on account of its involvement in important skin functions, including hair growth and sebum excretion. Malfunctioning of the pilosebaceous unit is the cause of common skin disorders, such as acne, seborrhea, dandruff, androgenic alopecia and hirsutism. Androgen metabolism plays an important role in the control of both sebum excretion rate (SER) and keratinization patterns in the pilosebaceous unit. The enzyme 5-a -testosterone reductase is responsible for the conversion of testosterone to dihydrotestosterone (DHT), and DHT is known to modulate both keratin formation and sebum production.1,2,3 Reducing sebum excretion is not an easy task. In his recent review, titled "Therapy For Acne Vulgaris", J. Leyden stated: "No topical therapies influence the production of sebum".4 Indeed, clinical studies with various topical anti-acne medications, including tretinoin and other retinoids, benzoyl peroxide and azelaic acid did not reveal any significant reduction of SER in acne and seborrhea - prone subjects.5,6,7,8 Topical application of the antiandrogen, inocoterone acetate did not reduce sebum excretion either.9 Other androgen antagonists, spironolactone and17-a -propylmesterolone, produced a significant reduction in SER, which occurred 12 weeks after the initiation of topical treatment.10,11 Interestingly, oral 13-cis-retinoic acid (accutan) and oral 9-cis-retinoic acid profoundly suppressed sebum excretion, with a long-lasting residual effect,12,13,14 whereas oral tretinoin did not.15